A stem cell transplant is a common treatment for multiple myeloma. If you’re able to have one, you’ll get induction therapy followed by a high dose of a chemotherapy drug to kill as many cancer cells as possible. Or your doctor might give you a combination of some of the other medici...
multiple myelomastandard-dose chemotherapybone resorptionbisphosphonatescytokinesmyelome multiplechimiotherapie conventionnelleresorption osseusebisphosphonatescytokinesAbout 50% of multiple myelong patients are older than 65 years and are not eligible for high-dose therapy, which has proved superior to standard-...
Combination chemotherapy for multiple myeloma Response rate, remission duration, and survival time were compared in 236 patients with multiple myeloma receiving a melphalan-prednisone-procarbazine comb... MD Raymond Alexanian,MD John Bonnet,E Gehan,... - 《Cancer》 被引量: 909发表: 1972年 Response...
Multiple myeloma emerging after chemotherapy for non- small cell lung cancer. Med Oncol 2008; 25:415-418.Marinopoulos S, Skorda L, Karatapanis S, Rasidakis A: Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer. Med Oncol 2008;25:415-418...
DOXORUBICIN/B.C.N.U. CHEMOTHERAPY FOR MULTIPLE MYELOMA IN RELAPSE 来自 Semantic Scholar 喜欢 0 阅读量: 51 作者:DS Alberts,BGM Durie,SE Salmon 摘要: A combination of doxorubicin ('Adriamycin') and B.C.N.U. (1,3 di[2-chloroethyl]-1-nitrosourea) (30 mg/m 2 of each drug intravenously...
P01.15. Multiple Myeloma, chemotherapy and curcuminP01.15. Multiple Myeloma, chemotherapy and curcuminHumansColitis, UlcerativeTerpenesMesalamineAnti-Inflammatory Agents, Non-SteroidalPlant PreparationsPlant ExtractsTreatment OutcomeDouble-Blind MethodRemission InductionMultiple Myeloma is one of the hematological mal...
multiple myeloma 浆细胞恶性增生性疾病。因为浆细胞主要在骨髓中,而且形成多发的瘤样浸润,故称MM。单克隆恶性浆细胞(即骨髓瘤细胞)的无限制增殖,可产生一种破骨细胞活化因子引起溶骨破坏和骨折;影响骨髓的造血功能,导致贫血和出血;产生大量单克隆免疫球蛋白(Ig),也称M蛋白,而正常 Ig明显下降,结果血液粘稠度可增高,...
L-PAM and prednisone (MP) has been challenged, almost from the start, by combination chemotherapy (CT) with its strong theoretic backing, as the standard chemotherapy for multiple myeloma. In effect, the two contestants were really evenly matched. Unfortunately, neither of them has been able to...
Chemoimmunotherapy for multiple myeloma Cancer, 47 (1981), pp. 1923-1929 View in ScopusGoogle Scholar 4 Alexanian R, Balcerzak S, Bonnet J, Gehan E, Haut A, Hewlett J, Monto R Prognostic factors in multiple myeloma Cancer, 36 (1975), pp. 1192-1201 View in ScopusGoogle Scholar 5 Hobbs...
The Future of Post-Autologous Stem Cell Transplant Therapy for Multiple Myeloma Multiple myeloma is a plasma cell malignancy characterized by lytic bone disease, monoclonal protein production, and immune dysregulation. For patients eligible for high-dose chemotherapy, the standard of care has been induct...